jaundice, the enzyme increment being possibly due to obstruction and partly secondary to hepatocellular damage. The level rarely exceeds 150 i.u./l. After relief of the obstruction, the level returns to normal in about a week. In cholecystitis, uncomplicated by either obstruction or cholangitis, the serum AsT remains normal. Secondary liver disease: In severe or prolonged congestive heart failure the serum AsT rises due to centrilobular hepatic necrosis. As the heart failure may be due to an infarction which has itself raised the AsT, such conditions may be difficult to sort out. The same difficulty applies in the detection of minor hepatic necrosis due to nicoumalone, when this possibly hepatoxic anticoagulant is being given to a patient after a myocardial infarction.
Alanine transaminase (AlT): This enzyme, formerly known as glutamic-pyruvic transaminase, is present in highest concentration in liver, and principally increases in the serum in cases of hepatocellular damage. The normal range is 4-13 i.u./l. at 250 C. Generally the serum AlT behaves in the same way as the serum AsT in various types of liver disease (Wroblewski 1958) . In most circumstances the serum AlT is altered slightly less than the AsT. This difference appears to be most consistent in cirrhosis and when there is carcinoma in the liver. On the other hand, in virus hepatitis the serum AlT may be raised slightly more than the serum AsT.
Some have considered that calculation of the AsT/AlT ratio is valuable in sorting out obscure cases of liver disease, but this is probably not so. The disadvantage of the AsT relative to the AlT is that it is generally less sensitive, and there is also the technical point that it is somewhat less stable in stored serum. The advantage of the AIT is that it does not increase significantly in serum after myocardial infarction, hence it is valuable in the mixed cardiac and hepatic cellular damage cases referred to above.
Isocitrate dehydrogenase (ICD): This enzyme is present in high concentration in both liver and cardiac muscle; its serum activity increases as a result of hepatocellular damage but not after myocardial infarction, unless there is secondary liver damage due to congestive failure. The normal range is 1-3 5 i.u./l. at 250 C. In general the pattern of response of serum ICD in liver disease is the same as that of the transaminases (Bell et al. 1962) . Special points are that in infectious mononucleosis the serum ICD is always raised at some stage during the disease, and that the test seems very sensitive to liver damage due to drugs. The serum ICD is almost always normal in extrahepatic obstructive jaundice (in contrast to the intrahepatic obstruction of biliary cirrhosis) unless there is secondary liver damage.
The particular advantage of ICD over the transaminases is this normality in obstructive jaundice. The estimation is more expensive, because the enzyme reaction requires the costly nicotinamide-adenine dinucleotide phosphate.
Conclusion
At present two different types of enzyme assay are necessary for the investigation of liver disease.
Alkaline phosphatase serves to measure biliary obstruction, though moderate increases are found in other types of liver disease. One of the metabolic enzymes serves to measure the rate of hepatocellular damage, particularly in assessing the activity of chronic liver disease and in detecting damage due to drugs.
Dr J H Wilkinson
(Department ofChemicalPathology, Westminster Medical School, London)
Isoenzymes, with Special Reference to New Enzyme Tests in Myocardial Infarction
The release of the enzymes of heart muscle into the serum after cardiac infarction was first observed by LaDue et al. (1954) , who reported transient elevation of the serum glutamicoxaloacetic transaminase (SGOT). The activities of several other serum enzymes (e.g. aldolase, malate dehydrogenase, lactate dehydrogenase) have since been shown to be increased for a few days after an episode. Unfortunately these enzymes are of dubious tissue specificity and in some cases frequent assay is necessary in order to detect the short-lived elevation of their activities in the serum.
The discovery of isoenzymes has led to important improvements in the diagnostic specificity of enzyme tests, especially in the case of lactate dehydrogenase (LD). Vesell & Beam (1957) and Wieland & Pfleiderer (1957) demonstrated that the LD of serum and various tissues consists of five different components separable by electrophoresis. These fractions are known as isoenzymes since they catalyse the same chemical reaction, i.e. the reversible reduction of pyruvate to lactate. The activities of isoenzyme fractions may be determined by the conventional colorimetric or spectrophotometric techniques. Staining techniques based upon the tetrazolium blue reaction have been devised for the detection of the various LD isoenzymes separated on starch gel, agar gel or cellulose acetate (Wieme 1959 , Van der Helm 1961 , Blanchaer 1961 , Latner & Skillen 1961 , Hawkins & Whyley 1962 , Barnett 1962 .
The electrophoretic patterns observed with extracts of different tissues appear to be organspecific: thus, at pH 8-6, heart LD consists principally of the fast-moving isoenzymes I and 2 which have mobilities similar to al-and a2globulins. Conversely, liver LD remains near the origin (LD6) and in this respect it behaves like a y-globulin.
Isoenzymes may be separated by techniques other than electrophoresis, e.g. by chromatography (Hess & Walter 1961) . Their existence is not confined to LD, and multiple forms of acid phosphatase, alkaline phosphatase, SGOT, isocitrate dehydrogenase and caeruloplasmin have been detected.
The appropriateness of the term 'isoenzyme' is now rather doubtful since the chemical and catalytic properties of the fast LD fractions have been shown to differ markedly from those of the slow components. Immunochemical differences have been observed by Nisselbaum & Bodansky (1959) and Plagemann et al. (1960) ; the slow components are relatively heat labile (Plagemann et al. 1961) ; and differences in Michaelis constants (Plagemann et al. 1960 , Vesell & Beam 1961 , ability to utilize coenzyme analogues (Kaplan et al. 1960 ), utilization of substrate analogues (Rosalki & Wilkinson 1960 , and in inhibitor constants ) have been reported.
'2-Hydroxybutyrate dehydrogenase': Quantitative electrophoretic separation of tissue and serum isoenzymes is a laborious procedure and in most laboratories is too time-consuming for routine use. We have therefore made a study of some of the chemical differences between the fast and slow LD isoenzymes. When separated by continuous paper electrophoresis LD1 and LD2 reduced 2-oxobutyrate as fast as the normal LD substrate, pyruvate, while the slow isoenzymes LD4 and LD5 were relatively inactive against this substrate (Rosalki & Wilkinson 1960 ). For convenience the name '2-hydroxybutyrate dehydrogenase' (HBD) has been used to indicate activity determined with 2-oxobutyrate though there is no evidence that it represents an entity distinct from the LD. However, determination of HBD activity does provide a convenient means for assessing the contribution of LD1 and LD2 to the total serum LD (SLD) activity.
It has been demonstrated that heart muscle, which is rich in LD1 and LD2, exhibits relatively high HBD activity (Plummer et al. 1963 ) and that isoenzymes with similar substrate affinities and electrophoretic mobilities are present in the serum of patients with myocardial infarction ). Comparisons of HBD and LD activities of extracts of a number of human and rabbit tissues showed that the HBD/LD ratio for heart muscle was about unity whereas that for liver was about 033.
Clinical Applications
Application of SHBD measurements to normal and pathological human sera gave the results summarized in Table 1 , which shows that in myocardial infarction significantly high values were observed. The SHBD/SLD ratio was also significantly elevated above the normal range but there was some overlap between the ratios observed in individual cases. SHBD activities were raised in a number of patients with infective hepatitis, but the SHBD/SLD ratio was markedly reduced below the normal range. In other forms of liver disease normal enzyme activities associated with slightly low ratios were observed. When congestive cardiac failure followed an episode of myocardial infarction, the dehydrogenase activities and ratios returned to normal, but subsequently the ratios fell to the subnormal values associated with liver damage. A comparison of the degrees of elevation of the SGOT, SLD and SHBD activities in confirmed cases of myocardial infarction showed the SHBD increase to be comparable with that for SGOT and appreciably greater than that of the SLD. Since the duration of SHBD elevation outlasted the increase in the levels of the other two enzymes, it seems that the SHBD might be the enzyme test of choice in the differential diagnosis of chest pain .
The incidence of false negative results appears to be low, for all cases of clinically diagnosed myocardial infarction, confirmed either by means of the electrocardiograph or by the finding of elevated SGOT or SLD activities, had raised SHBD activities. In a series of 209 cases in which the diagnosis of infarction or ischlemia was considered, the SHBD level was abnormal in 122 (58 %). By contrast only 88 (42%) exhibited raised SGOT activities and the same number (42%) (though not necessarily the same individuals) had raised SLD activities. Since at least one index of infarction (e.g. electrocardiograph, SGOT, SLD, post-mortem examination), other than clinical assessment, was also abnormal in each of the cases in which elevated SHBD levels were observed, it is considered that false positive results are also of infrequent occurrence.
Normal values were encountered in patients with chest pain due to pulmonary infarction, pericarditis, acute cholecystitis and biliary colic, hiatus hernia, acute rheumatic fever and rheumatic valvular disease of the heart. In 62 cases finally diagnosed as angina of effort 9 showed marginally raised SHBD activities while the remainder had normal levels.
In acute hepatocellular diseases raised activities were sporadically observed, but the SHBD/SLD ratio in practically all cases was abnormally low . Malignant diseases involving the liver were also characterized by low SHBD/SLD ratios, whereas those without evidence of liver metastases usually had normal ratios. The only non-cardiac conditions so far encountered in which elevated activities were regularly associated with abnormally high SHBD/SLD ratios were certain megaloblastic anwmias (during therapy) and progressive muscular dystrophy.
It seems therefore that the SHBD test merits further evaluation as a test for myocardial infarction.
Introduction
While carrying out a study of the enzyme aldolase in animal tissues Sibley & Lehninger (1949) observed a high serum activity in two patients with progressive muscular dystrophy. Further observations by a number of workers (Sibley & Fleisher 1954 , Evans & Baker 1957 , Dreyfus et al. 1958 , Thompson & Vignos 1959 confirmed these findings and showed that indeed the serum activity of several enzymes was raised in muscular dystrophy and in other primary diseases of muscle, notably acute dermatomyositis. On the other hand the serum activities in patients with muscle disorders secondary to denervation were normal. This means that in the primary, as opposed to the secondary, myopathies abnormal amounts of cellular enzymes are found outside the cells.
Enzymes with Raised Serum Activity in Muscle Disease
Examples of enzymes with a raised serum activity in primary muscle disease are phosphohexose isomerase, aldolase, lactate dehydrogenase, all
